Hematopoietic stem-cell transplantation for myelodysplastic syndromes

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 31 Jan 2024: Trial registered, NCT06235398

The trials

NCT06235398: Upfront Related Donor Transplantation in Patients With Myelodisplatic Syndrome : a Phase 2 Trial

State
Not started
Phase
Phase 2
People
55 planned
Started
1 Feb 2024
Primary completion
1 Feb 2028
Arms
Adults with Myelodysplasic Syndrome diagnosis
Results
None posted
  1. 31 Jan 2024: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.